Results 41 to 50 of about 9,772 (228)

Dihydroergotamine, ergotamine, methysergide and sumatriptan - Basic science in relation to migraine treatment [PDF]

, 2012
The 5-hydroxytryptamine (5-HT) receptor family mediates the effects of several drugs highly effective in migraine primarily by activating 5-HT 1B, 5-HT1D, and 5-HT1F receptors.
Dahlöf, C. (Carl), Maassen van den Brink, A. (Antoinette)   +1 more
core   +3 more sources

Conventional cigarettes, novel heated tobacco products, and self‐reported frequent headache association in Japanese individuals: Insights from the JASTIS study, a Japanese cross‐sectional analysis

Headache: The Journal of Head and Face Pain, EarlyView.
Plain Language Summary Headache is a common health problem, and tobacco products, such as conventional cigarettes and heated tobacco products (HTPs), may be associated with it. Using data from over 23,000 adults in the Japan Society and New Tobacco Internet Survey, we examined the relationships between cigarette and HTP use and self‐reported frequent ...
Masahito Katsuki, Kieran Moran, Muneto Tatsumoto, Keisuke Suzuki, Tomokazu Shimazu, Yasuhiko Matsumori, Yutaro Fuse, Miguel Á. Huerta, Daijiro Sugiyama, Jackson T. S. Cheung, Siobhán O'Connor, Tomás Ward, Takahiro Tabuchi   +12 more
wiley   +1 more source

The putative proton-coupled organic cation antiporter is involved in uptake of triptans into human brain capillary endothelial cells

Fluids and Barriers of the CNS
Background Triptans are anti-migraine drugs with a potential central site of action. However, it is not known to what extent triptans cross the blood–brain barrier (BBB).
Nana Svane, Alberte Bay Villekjær Pedersen, Anne Rodenberg, Burak Ozgür, Lasse Saaby, Christoffer Bundgaard, Mie Kristensen, Peer Tfelt-Hansen, Birger Brodin   +8 more
doaj   +1 more source

Headaches attributed to airplane travel:a Danish survey [PDF]

, 2016
BACKGROUND: Airplane headache (AH) is a headache that occurs during take-off and landing. The pain is described as severe, unilateral, and located in the fronto-orbital region.
Bui, Sebastian Bao Dinh, Gazerani, Parisa, Petersen, Torben, Poulsen, Jeppe Nørgaard   +3 more
core   +2 more sources

Randomized controlled trial of intravenous dexamethasone to prevent relapse in the treatment of migraine in a pediatric emergency department

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective This study aimed to evaluate whether a single dose of intravenous dexamethasone, when added to standard abortive therapy, reduces relapse of migraine after emergency department (ED) discharge in children and adolescents. Background Migraine is a leading cause of headache presentations to the ED for children and adolescents.
Geneviève Tourigny‐Ruel, Benoit Bailey, Sabrina Jean‐Charles, Jocelyn Gravel   +3 more
wiley   +1 more source

Parasomnias and sleep‐related movement disorders induced by drugs in the adult population: a review about iatrogenic medication effects

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont, Vanessa Bloch, Agnès Lillo‐Lelouet, Christine Le Beller, Pierre A. Geoffroy, Marc Veyrier   +5 more
wiley   +1 more source

Stroke and migraine is there a possible comorbidity? [PDF]

, 2016
The association between migraine and stroke is still a dilemma for neurologists. Migraine is associated with an increased stroke risk and it is considered an independent risk factor for ischaemic stroke in a particular subgroup of patients.
Del Balzo, Francesca, Duse, Marzia, Nicita, Francesco, Occasi, Francesca, Papetti, Laura, Properzi, Enrico, Spalice, Alberto, Zicari, Anna Maria   +7 more
core   +2 more sources

Pharmacologic MRI Brain Imaging Studies of Serotonin 5‐HT1 Receptor Agonists in Awake Mice

Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
ABSTRACT Serotonin (5‐hydroxytryptamine, 5‐HT) type‐1 G protein‐coupled receptors are expressed throughout the central nervous system. 5‐HT1AR activation is the putative mechanism of approved drugs for generalized anxiety disorder and major depressive disorder and is being studied in the treatment of autism and neurological disorders.
Brittany M. Brems, Erin E. Sullivan, Ryan P. McGlynn, Praveen Kulkarni, Craig F. Ferris, Raymond G. Booth   +5 more
wiley   +1 more source

Review of frovatriptan in the treatment of migraine

Neuropsychiatric Disease and Treatment, 2008
Leslie KelmanHeadache Center of Atlanta, Atlanta, GA, USAAbstract: Triptans are recommended for the acute treatment of moderate to severe migraine or failure to respond to other acute migraine treatments.
Leslie Kelman
doaj  

Reimbursement-based economics - What is it and how can we use it to inform drug policy reform? [PDF]

, 2015
BACKGROUND: In Ontario, approximately $3.8 billion is spent annually on publicly funded drug programs. The annual growth in Ontario Public Drug Program (OPDP) expenditure has been limited to 1.2% over the course of 3 years. Concurrently, the Ontario Drug
Adelman, Asseburg, Belsey, Belsey, Canadian Agency for Drugs and Technologies in Health, Canadian Agency for Drugs and Technologies in Health, Duffy, Evans, Ferrari, Hens, Ilersich, Kelman, Mullins, Mullins, National Clinical Guideline Centre, Ontario Drug Policy Research Network, Ontario Drug Policy Research Network, Payne, Perfetto, Ramsberg, Reeder, Slof, Thompson, Wells, Williams, Williams, Zhang   +26 more
core   +1 more source